Taking Cancer Support to a New Level

Adjuvant therapy with aspirin offers no protection against recurrence or survival benefit in patients with high-risk nonmetastatic breast cancer, the results of a new phase 3 randomized controlled trial suggest.

It takes a certain amount of confidence to call your biotech company Grail.

New research suggests patients with an average risk of colon cancer may only need to undergo a colonoscopy screening every 15 years instead of the recommended 10.

It’s a long-standing myth that breast cancer only affects older women.